Abstract

Loranthus regularis Steud. ex Sprague (Loranthaceae) aerial part is widely used for medicinal purposes. To evaluate its anti-inflammatory, antinociceptive and antipyretic activities, two concentrations of the extract and its fractions were tested in carrageenan-induced rat paw oedema, hot-plate test model in mice and brewer’s yeast-induced pyrexia in mice. The antioxidant power of the extract, its fractions and isolated compounds was studied using DPPH scavenging and β-carotene/linoleic acid tests. The ethyl acetate fraction of a methanol extract was found to be the most active fraction and exhibited the highest inhibition of inflammation (67%) and the highest inhibition of oxidation of β-carotene (92%). Bioassay-guided fractionation of the ethyl acetate fraction was carried out and three flavonoid glycosides were isolated for the first time from this species: ( 1) quercetin 3- O-β- l-galactopyranoside, ( 2) quercetin 3- O-β- l-arabinopyranoside and ( 3) quercetin 3- O-α- l-rhamnopyranoside. The present results confirmed the traditional use of L. regularis and clearly indicate that the plant could be a potential anti-inflammatory and antioxidant agent.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call